Metastatic Gastric Adenocarcinoma Not Yet Recruiting Phase 1 / 2 Trials for Trifluridine (DB00432)

Also known as: Adenocarcinoma gastric / Adenocarcinoma of stomach (disorder)

IndicationStatusPhase
DBCOND0074521 (Metastatic Gastric Adenocarcinoma)Not Yet Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05927857Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .Treatment